The Effect of Hemodialysis Adequacy on Inflammatory Status in Stage 5 Chronic Kidney Disease Patients
(A Study at Dr. Adhyatma, MPH Regional Hospital, Semarang)
Abstract
Background: Chronic Kidney Disease (CKD) is a critical global health issue, particularly Stage 5 CKD, where kidney function is severely impaired. Hemodialysis, essential for managing such patients, aims to remove waste and excess fluids. Chronic inflammation, common among CKD5-HD patients, heightens cardiovascular risks and worsens quality of life. Hemodialysis adequacy, measured by the Kt/V ratio, plays a vital role in outcomes, yet its relationship with inflammatory markers, such as Hs-CRP, albumin, and TIBC, remains unclear.
Objective: This study aimed to evaluate the relationship between hemodialysis adequacy, as reflected by Kt/V values, and inflammatory markers such as c-reactive protein (CRP), albumin, and total iron binding capacity (TIBC) in CKD stage 5 patients undergoing hemodialysis, providing insights into optimizing dialysis protocols to mitigate inflammation.
Methods: A cross-sectional study of 45 CKD5-HD patients assessed Kt/V values and inflammatory markers (Hs-CRP, albumin, TIBC). Data were analyzed using Shapiro-Wilk, Independent t-tests, or Mann-Whitney U tests based on data distribution.
Results: The mean Kt/V value was 1.31 ± 0.21. Lower Kt/V values were significantly associated with elevated Hs-CRP levels (p = 0.018). No significant differences in Kt/V values were observed concerning albumin (p = 0.546) or TIBC (p = 0.523). Correlations between Hs-CRP and albumin or TIBC were non-significant (p = 1.000).
Conclusion: Adequate hemodialysis, reflected in optimal Kt/V values, is crucial for reducing systemic inflammation marked by Hs-CRP. Albumin and TIBC levels showed no significant association, underscoring the multifactorial nature of inflammation in CKD5 patients.
Downloads
References
2. Badan Penelitian dan Pengembangan Kesehatan. Penyakit gagal ginjal kronis. In: Laporan Nasional Riskesdas 2018. Jakarta: Kementerian Kesehatan RI; 2018. p. 169–74.
3. Afiatin. 13th Annual Report of Indonesian Renal Registry 2020. 2023.
4. Ai S, Xu Q, Chen G, Zheng K, Qin Y, Li X. Effects of hemodialysis adequacy on chronic kidney disease complications using latent class trajectory modeling: a real-world study based on long-term observation of Kt/V. Front Med. 2024;11:1449919. doi:10.3389/fmed.2024.1449919
5. Daugirdas JT, Depner TA, Greene T, Kuhlmann MK, Levin NW, Chertow GM. Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area—implications for different-size patients by gender. Semin Dial. 2008;21(5):415–421. doi:10.1111/j.1525-139x.2008.00482.x
6. Lestariningsih L, Hardisaputro S, Nurani A, Santosa D, Santoso G. High sensitivity C-reactive protein as a predictive of intima-media thickness in patients with end-stage renal disease on regular hemodialysis. Int J Gen Med. 2019;12:219–24. doi:10.2147/ijgm.s205506
7. Valga F, Monzón T, Vega-Diaz N, Rodriguez-Perez JC, Ruiz-Santana S. Inflammation and hemodialysis adequacy: are C-reactive protein levels influenced by the dose of dialysis? Nefrologia. 2022;42(2):163–70. doi:10.1016/j.nefroe.2021.06.005
8. Jeon J, Kim GO, Kim BY, Son EJ, Do JY, Lee JE, et al. Effects of Kt/V urea on outcomes according to age in patients on hemodialysis. Clin Kidney J. 2024;17(5):sfae116. doi:10.1093/ckj/sfae116
9. Hanafusa N, Nitta K, Okazaki M, Komatsu M, Shiohira S, Kawaguchi H, et al. Serum albumin level adjusted with C-reactive protein predicts hemodialysis patient survival. Ren Replace Ther. 2017;3:9. doi:10.1186/s41100-016-0085-4
10. Graterol Torres F, Molina M, Soler-Majoral J, Romero-Gonz’alez G, Rodr’iguez Chitiva N, Troya-Saborido M, et al. Evolving Concepts on Inflammatory Biomarkers and Malnutrition in Chronic Kidney Disease. Nutrients. 2022;14(20):4297. doi:10.3390/nu14204297
11. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition- inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003;42(5):864–81. doi:10.1016/j.ajkd.2003.07.016
12. Nugroho P, Lydia A, Susalit E. Change of interleukin-6, C-reactive protein and soluble vascular cell adhesion molecule-1 concentrations in hemodialysis patients with reprocessed dialyzer. J Penyakit Dalam Indones. 2016;3(3):131–7. doi:10.7454/jpdi.v3i3.23
13. Bross R, Zitterkoph J, Pithia J, Benner D, Rambod M, Kovesdy CP, et al. Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients. Am J Nephrol. 2009;29(6):571–81. doi:10.1159/000191470
14. Kaysen GA, Dubin JA, Muller HG, Rosales L, Levin NW, Mitch WE, et al. Relationships among inflammation, nutrition, and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int. 2002;61(6):2240–2249. doi:10.1046/j.1523-1755.2002.00076.x
15. Castillo JCM, Sanabria M, Vesga J, Aldana A, Sánchez R, Buitrago G. Albumin, inflammation and nutrition in hemodialysis patients in Colombia: a cohort study. Nephrol Dial Transpl. 2024;39(Supplement_1):gfae069-1531–704. doi:10.1093/ndt/gfae069.1531
16. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial. 2002;15(5):329–337. doi:10.1046/j.1525-139x.2002.00083.x
Copyright (c) 2025 Indonesian Journal of Kidney and Hypertension
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Indonesian Journal of Kidney and Hypertension agree to the following terms:
- Authors retain copyright and grant Indonesian Journal of Kidney and Hypertension right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Indonesian Journal of Kidney and Hypertension.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Indonesian Journal of Kidney and Hypertension.
1.png){kind=logo}
